HRT Financial’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11K Buy
+11,276
New +$19.1K ﹤0.01% 3631
2025
Q3
Sell
-9,148
Closed -$42K 3751
2025
Q2
$42K Buy
+9,148
New +$49.5K ﹤0.01% 2328
2024
Q4
Sell
-1,046
Closed -$7K 3325
2024
Q3
$7K Buy
+1,046
New +$33.6K ﹤0.01% 2252
2022
Q4
Sell
-15
Closed -$16K 3225
2022
Q3
$16K Buy
+15
New +$28.5K ﹤0.01% 2503

Other funds holding VTAK

HRT Financial's VTAK Position: Q1 2026 in Review

HRT Financial opened a new position in Catheter Precision (VTAK) in Q1 2026: 11,276 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #3631 among its holdings. This is a return to the name: HRT Financial previously reported a position in VTAK as recently as Q2 2025.

HRT Financial first reported a position in VTAK in Q3 2022 and has held it in 4 quarters since. The position peaked at $42K in Q2 2025. 12 funds tracked by Wall St. Rank hold VTAK as of Q1 2026.

  • HRT Financial held 11,276 shares of Catheter Precision worth $11K as of Q1 2026.
  • Catheter Precision was a new HRT Financial position in Q1 2026.
  • Catheter Precision made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3631 holding.
  • HRT Financial first reported a position in Catheter Precision in Q3 2022 and has held it in 4 quarters since.
  • HRT Financial's Catheter Precision position peaked at $42K in Q2 2025.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.